Tim Kaine actually said...

the challenges associated with developing treatments and the investments we make to develop novel medicines, that is really completely a red herring with respect to Syprine.

Context

Kaine criticizes Valeant's justification for price increases on Syprine.

04/26/2016

https://www.congress.gov...

More Tim Kaine Quotes

Not everybody can access a 4-year degree or even a 2-year degree. But we also know that by 2031, more than 70 percent of jobs will require s...
6/12/2024
Who's going to build it? Who's going to make it? This is a challenge that I'm hearing from all my employers.
6/12/2024
Who's going to build it? Who's going to make it? This is a challenge that I'm hearing from all my employers.
6/12/2024
That's why I have long been a champion of expanding Pell Grant to include high quality short-term education and training programs.
6/12/2024

View All Tim Kaine Quotes